Fact-checked by Grok 2 weeks ago

Cervical lymph nodes

The cervical lymph nodes are a large group of lymphoid structures located throughout the , forming a critical component of the in the head and region. These nodes, numbering over 300 in total across the head and , are organized into superficial and deep chains that filter lymph fluid, trap pathogens, and facilitate immune responses by transporting antigens to lymphocytes. They primarily drain lymphatic fluid from the , face, oral cavity, , , , gland, and parts of the , ultimately converging into the jugular lymphatic trunks that empty into the venous system via the on the left or the right lymphatic duct. Anatomically, the cervical lymph nodes are classified into several levels for clinical and surgical purposes, including submental (level Ia), submandibular (level Ib), upper jugular (level II), middle jugular (level III), lower jugular (level IV), posterior triangle (level V), and anterior compartment (level VI), with additional levels such as retropharyngeal and supraclavicular nodes. The superficial nodes, such as occipital, mastoid, parotid, submental, and submandibular groups, lie closer to the skin and drain specific superficial structures like the , , and face, while the deep nodes, aligned along the and , receive efferent vessels from the superficial nodes and handle the bulk of drainage from deeper structures including the and . This hierarchical organization ensures efficient unidirectional flow, with minimal cross-communication between left and right sides under normal conditions. Clinically, cervical lymph nodes are significant for their role in detecting and malignancies, as they are common sites for from head and neck cancers, thyroid carcinomas, and even distant abdominal tumors via the left supraclavicular node (Virchow's node). Their enlargement, known as , can indicate infections, autoimmune disorders, or neoplasms, guiding diagnostic imaging, biopsies, and treatments like in . Understanding their precise anatomy and drainage patterns is essential for radiotherapy planning and surgical interventions to preserve vital structures like the and .

Anatomy

Location and distribution

The cervical lymph nodes constitute approximately 300 of the 600 to 800 lymph nodes distributed throughout the , forming a critical component of the lymphatic network in the head and region. These nodes are anatomically positioned within the , extending from the skull base superiorly to the inferiorly, and are bounded laterally by the anterior border of the and the posterior border of the muscle. Specific zones of concentration include the at the base of the and the retropharyngeal posterior to the . Cervical lymph nodes are broadly divided into superficial and deep groups based on their relation to the deep cervical fascia. The superficial nodes, numbering fewer than the deep ones, are situated along the course of the external jugular vein and include subgroups such as the occipital nodes at the base of the skull, mastoid nodes behind the ear, parotid nodes anterior to the ear, and facial nodes along the face. In contrast, the deep nodes align with the internal jugular vein within the carotid sheath and encompass anterior groups (such as prelaryngeal and pretracheal nodes in the midline), lateral groups (along the jugular chain), and posterior groups (in the posterior triangle). Distribution patterns further delineate these into anterior cervical nodes (including submental nodes above the hyoid in the submental triangle and submandibular nodes in the submandibular triangle), lateral nodes (comprising upper, middle, and lower jugular subgroups), posterior triangle nodes (behind the sternocleidomastoid), and central compartment nodes (around the trachea and thyroid). These groupings correspond briefly to the standard lymph node levels I through VI used in clinical anatomy. The number and size of cervical lymph nodes exhibit age-related variations, with children possessing a higher density of lymph nodes and often having multiple palpable nodes up to 1 cm in diameter considered normal due to active lymphoid development, while adults typically have fewer, smaller nodes averaging 0.5 to 1 cm. In the elderly, progressive occurs, characterized by reduced node size, decreased cellularity, and increased , leading to fewer functional nodes overall.

Structure and histology

Cervical lymph nodes, like other secondary lymphoid organs, are encapsulated structures that filter and facilitate immune responses. The outermost layer consists of a thin fibrous capsule composed of and fibers, which extends inward as trabeculae to provide structural support and divide the node into compartments. Afferent lymphatic vessels penetrate the capsule to deliver into the subcapsular , a continuous space beneath the capsule that serves as the initial site for and trapping of . The cortex, located just beneath the subcapsular sinus, is the primary site of B-cell activity and is divided into follicular and paracortical regions. The outer follicular area contains primary lymphoid follicles composed of naïve B cells in the absence of stimulation, which upon encounter develop into secondary follicles featuring prominent germinal centers. These germinal centers are dynamic structures where B-cell proliferation, , and affinity maturation occur, supported by that retain antigens on their surfaces. The adjacent paracortex, or deep cortex, is predominantly populated by T lymphocytes and high endothelial venules (HEVs), specialized post-capillary venules that express adhesion molecules to enable the homing and trafficking of naïve T and B cells from the bloodstream into the . The medulla forms the innermost region, characterized by medullary cords and sinuses that contain a mix of plasma cells, macrophages, and residual lymphocytes. Medullary cords are linear aggregates of immune cells responsible for antibody secretion, while the medullary sinuses facilitate the exit of efferent through the hilum, the indented region where arteries enter, veins and efferent lymphatics exit, and innervate the . Key cellular components across these compartments include B and T lymphocytes, which constitute the majority of resident cells; macrophages that phagocytose debris in the sinuses; and dendritic cells that bridge innate and adaptive immunity by presenting antigens to T cells in the paracortex. In normal cervical lymph nodes, the short-axis diameter typically measures less than 1 cm, reflecting a baseline state without significant antigenic challenge. , a common adaptive response, manifests histologically as enlargement of follicles with expanded germinal centers and increased paracortical cellularity, indicating active immune engagement without .

Classification

Historical developments

The earliest descriptions of structures resembling cervical lymph nodes date back to and medicine, where they were referred to as "gland-like" swellings in the neck associated with inflammatory or infectious processes. , in the treatise On Glands (Peri adenôn) from the 5th-4th century BCE, described whitish, spongy glands near the jugular vessels and around the ears, interpreting them as sites for the collection and excretion of phlegm-like fluids to maintain bodily balance. , the physician of the 2nd century CE, expanded on these observations in his anatomical works, noting similar glandular masses in the neck as part of a vascular that could become enlarged due to humoral imbalances or , though without recognizing their lymphatic role. In the 17th and 18th centuries, European anatomists began more systematically naming and delineating superficial lymphatic chains in the neck as part of broader studies on glandular anatomy. Thomas Wharton, in his 1656 treatise Adenographia, provided one of the first detailed classifications of glands, including those in the cervical region, describing them as interconnected structures involved in fluid secretion and nervous system support, based on dissections that highlighted superficial chains along the neck's anterior and lateral aspects. Lorenz Heister, in the mid-18th century, further contributed by documenting surgical approaches to enlarged neck glands in his surgical handbook, emphasizing superficial chains for excisional procedures in cases of suppuration or scrofula. Advancements in the 19th and early 20th centuries shifted focus toward pathological and functional understanding, with Henri Rouvière's 1932 textbook Anatomie des Lymphatiques de l'Homme establishing a foundational 10-group classification for cervical lymph nodes, dividing them into anterior, lateral, and deep categories based on anatomical landmarks like muscle attachments and vascular relations. Concurrently, Rudolf Virchow's pathological observations in the mid-19th century highlighted metastatic involvement, notably describing the left supraclavicular node (Virchow's node) as a sentinel for abdominal malignancies spreading via drainage, influencing recognition of predictable cervical metastatic patterns in cancers. The mid-20th century marked a transition to clinically oriented nomenclature, driven by oncologic surgery. George Crile Sr. introduced radical neck dissection in 1906 at the Cleveland Clinic, grouping cervical nodes into en bloc resections for head and neck cancers to address regional spread, which laid groundwork for standardized surgical mapping. In the 1940s-1960s, Hayes Martin at Memorial Sloan Kettering Cancer Center refined these into practical groupings for comprehensive lymphadenectomy, incorporating spinal accessory nerve sacrifice and emphasizing radical excision to improve survival in squamous cell carcinoma. These historical systems, however, suffered from key limitations, including inconsistent terminology across anatomists and surgeons, vague boundaries that hindered reproducible dissections, and a lack of integration with emerging imaging modalities, prompting later standardization efforts that built toward modern level-based systems like I-VI.

Modern level-based systems

The modern level-based classification of cervical lymph nodes, developed by the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), was first published in 1991 to standardize nomenclature for describing nodal anatomy and involvement in head and neck oncology, enabling consistent reporting across surgical, radiological, and pathological disciplines. This system delineates six primary levels (I through VI) using reproducible anatomical landmarks, including bones (e.g., mandible, clavicle), muscles (e.g., sternocleidomastoid, digastric), vessels (e.g., internal jugular vein), and nerves (e.g., spinal accessory nerve), to address inconsistencies in prior descriptive terms like "deep cervical chain." The framework was revised in 2002 to incorporate sublevels (e.g., IIA/B, VA/B) for enhanced precision in identifying at-risk nodes during targeted therapies and imaging, particularly subdividing levels II and V by the course of the spinal accessory nerve and transverse cervical vessels. A further consensus update in 2008 refined these boundaries without altering the core structure, solidifying the system's role in contemporary practice. The levels are defined as follows, with boundaries ensuring compatibility with cross-sectional imaging modalities like CT and MRI (based on AAO-HNS 2008 guidelines):
LevelDescriptionSuperior BoundaryInferior BoundaryAnterior (Medial) BoundaryPosterior (Lateral) Boundary
I (Submental/Submandibular)Includes submental (IA) and submandibular (IB) nodes; sublevels separated by mylohyoid muscle.IA: Symphysis of mandible
IB: Body of mandible
IA: Body of hyoid bone
IB: Posterior belly of digastric muscle
IA: Anterior belly of contralateral digastric muscle
IB: Anterior belly of digastric muscle
IA: Anterior belly of ipsilateral digastric muscle
IB: Stylohyoid muscle
II (Upper Jugular)Upper internal jugular chain; IIA anterior to spinal accessory nerve, IIB posterior.Skull baseInferior border of hyoid boneIIA: Stylohyoid muscle
IIB: Vertical plane of spinal accessory nerve
Posterior border of sternocleidomastoid muscle
III (Middle Jugular)Middle internal jugular chain.Inferior border of hyoid boneInferior border of cricoid cartilageLateral border of sternohyoid musclePosterior border of sternocleidomastoid muscle or sensory branches of cervical plexus
IV (Lower Jugular)Lower internal jugular chain.Inferior border of cricoid cartilageClavicleLateral border of sternohyoid musclePosterior border of sternocleidomastoid muscle or sensory branches of cervical plexus
V (Posterior Triangle)Posterior triangle nodes; VA above transverse cervical vessels, VB below.Apex of convergence of sternocleidomastoid and trapezius musclesVA: Lower border of cricoid cartilage
VB: Clavicle
Posterior border of sternocleidomastoid muscle or sensory branches of cervical plexusAnterior border of trapezius muscle
VI (Anterior/Central Compartment)Prelaryngeal, pretracheal, paratracheal nodes.Hyoid boneSuprasternal notchCommon carotid arteriesCommon carotid arteries
These definitions, sourced from AAO-HNS guidelines, prioritize clinical utility by aligning with common metastatic patterns in head and neck squamous cell carcinoma. The American Joint Committee on Cancer (AJCC) and Union for International Cancer Control (UICC) incorporated this level-based system into the 8th edition of their TNM staging manual for head and neck cancers, published in 2017 and effective from January 2018, to integrate anatomical precision with prognostic stratification. For thyroid malignancies, the 8th edition explicitly adds level VII (superior mediastinal nodes), defined as nodes inferior to the suprasternal notch and superior to the innominate artery between the carotid arteries, classifying involvement here as N1a alongside level VI. This expansion reflects the prognostic relevance of mediastinal extension in differentiated thyroid cancer without disrupting the core cervical framework. The primary rationale for these systems is to promote interdisciplinary communication, improve treatment planning, and support evidence-based decisions, as evidenced by their widespread adoption in guidelines from the American Head and Neck Society. No substantive revisions to the level definitions have occurred since the AJCC/UICC implementation, according to comprehensive reviews as of 2025, including the AJCC/UICC 9th edition (effective January 2025). In clinical application, the system underpins N-category staging; for example, denotes metastasis to a single ipsilateral node no greater than 3 cm in greatest dimension within a single level, while higher categories (N2, N3) account for size, laterality, and extracapsular extension across levels.

Function

Lymphatic drainage

The cervical lymph nodes serve as the primary filtration sites for lymph originating from the head and , with drainage patterns organized by anatomical levels I through VI as defined in modern classification systems. Level I nodes, located submentally and submandibularly, primarily receive afferent from the oral cavity structures including the , , teeth, anterior , floor of the mouth, and face. Level II nodes in the upper jugular chain drain the oropharynx, , nasopharynx, and . Levels III and IV, in the middle and lower jugular chains, handle drainage from the hypopharynx, gland, and portions of the and . Level V nodes in the posterior filter from the , of the , and posterior nasopharynx and oropharynx. Level VI nodes in the anterior compartment primarily drain the , parathyroid glands, , and upper . Afferent lymphatic flow to these nodes follows unidirectional patterns from peripheral tissues to central chains, ensuring sequential ; for instance, from the nasopharynx initially enters retropharyngeal nodes before progressing to the jugular chain. Midline structures such as the exhibit bilateral drainage, allowing to reach ipsilateral and contralateral cervical nodes for comprehensive coverage. This organized inflow supports efficient transport of interstitial fluid, proteins, and particulates from the drained regions. Efferent vessels from the cervical nodes converge into jugular lymphatic trunks, which ultimately empty into the thoracic duct on the left side or the right lymphatic duct on the right, rejoining the venous circulation at the subclavian veins. In certain pathological scenarios like cancer, skip metastases can occur, where malignant cells bypass intermediate nodal levels and directly involve more distant nodes. Physiologically, the cervical lymph nodes process a portion of the body's daily flow, estimated at 2-4 liters overall, with targeting antigens and particles to prevent systemic spread. This volume varies with activity and hydration but underscores the nodes' role in maintaining and clearing debris from head and tissues.

Immune surveillance

Cervical lymph nodes play a pivotal role in immune by facilitating the detection and response to antigens derived from the head and region, particularly through the migration of dendritic cells from mucosal surfaces. Dendritic cells capture pathogens or antigens in the oral, pharyngeal, or and traffic to the paracortical regions of draining cervical lymph nodes, where they present processed antigens via ( and II molecules to naïve T cells. This interaction initiates T cell activation and differentiation into effector cells, enabling a coordinated adaptive against invading microbes. Concurrently, B cells in the follicular regions of these nodes encounter antigens delivered via , leading to their activation, proliferation, and differentiation into plasma cells that produce antibodies, thereby amplifying . Lymphocyte recirculation ensures continuous immune monitoring within cervical lymph nodes, with naïve T and B cells entering the nodes through specialized high endothelial venules (HEVs) that express molecules such as PNAd and CCL21 to facilitate selective trafficking from the bloodstream. Upon and maturation, these lymphocytes the nodes via efferent lymphatic vessels to patrol peripheral tissues, including the oral and pharyngeal mucosa, where memory T and B cells provide rapid responses to recurrent threats from local pathogens. This dynamic recirculation maintains a vigilant pool of immune cells tailored to the unique antigenic challenges of the upper aerodigestive tract. Specific adaptations in cervical lymph nodes enhance their role in mucosal immunity, including elevated production of IgA antibodies driven by antigens draining from mucosal sites, which promotes non-inflammatory neutralization of pathogens at epithelial barriers. These nodes also balance to commensal flora in the oral cavity—achieved through induction and IgA coating of harmless microbes—with robust responses to viral threats like Epstein-Barr virus (EBV), where activated B cells and T cells in the mount antiviral defenses to control latent infections. Under steady-state conditions, lymphocyte populations in cervical lymph nodes undergo basal homeostatic to sustain immune readiness, a process modulated by cytokines such as IL-2 that promote T cell survival and expansion without overt inflammation. This turnover, occurring primarily in the paracortex and follicles, ensures replenishment of naïve and memory cells while integrating signals from the paracortical T cell zones and medullary sinuses.

Clinical significance

Reactive lymphadenopathy

Reactive lymphadenopathy refers to the non-malignant enlargement of cervical lymph nodes resulting from an exaggerated to stimuli such as , , or autoimmune disorders, characterized by without evidence of neoplasia. This condition is distinguished by its reversibility upon resolution of the underlying trigger, often involving architectural changes in the node such as expanded germinal centers and paracortical expansion. Infectious causes predominate, with viral etiologies like Epstein-Barr virus (EBV) in commonly leading to tender, bilateral enlargement of nodes in levels II and III, accompanied by systemic symptoms such as fever and . Bacterial infections, such as those from in , typically produce unilateral, tender involvement of level II nodes, often resolving with antibiotic therapy. Fungal infections, including in endemic regions like the and valleys, can cause persistent through granulomatous inflammation, particularly in immunocompromised individuals. Autoimmune processes also contribute, as seen in Sjögren's syndrome, where chronic inflammation of salivary glands leads to persistent enlargement of nodes, particularly in level I (submandibular), due to reactive . Similarly, often presents with bilateral featuring non-caseating granulomas on , reflecting systemic granulomatous inflammation. These autoimmune-related enlargements tend to be less tender and more chronic compared to infectious causes. Clinically, reactive cervical lymphadenopathy manifests as nodes exceeding 1 cm in short-axis diameter, with features of tenderness indicating acute inflammation, mobility on palpation, and absence of fixation to surrounding tissues, all supporting a benign etiology. Resolution typically occurs within 3-4 weeks following treatment of the underlying cause, such as antibiotics for bacterial infections or supportive care for viral illnesses, though autoimmune cases may require disease-specific management for subsidence. Epidemiologically, reactive lymphadenopathy is most prevalent in children and young adults, driven by frequent encounters with infectious agents; approximately 90% of children aged 4-8 years exhibit palpable nodes, and reactive causes account for about 66% of pediatric neck masses evaluated in clinical settings. In broader populations, over 50% of head and neck are reactive, underscoring its commonality in .

Neoplastic involvement

Cervical lymph nodes serve as a primary site for regional in various head and neck malignancies, significantly influencing disease staging and patient outcomes. In head and neck (HNSCC), approximately 40-60% of cases present with cervical lymph node involvement at diagnosis, with initial spread commonly occurring to levels II-IV. This pattern underscores the nodes' role in lymphatic dissemination, where involvement often correlates with tumor aggressiveness and distant risk. Metastasis patterns vary by primary tumor site. For oral cavity cancers, level I nodes are most frequently affected, followed by levels II and III. Nasopharyngeal s preferentially involve levels II and V, often with retropharyngeal nodes, while laryngeal tumors typically metastasize to levels III and IV. In papillary , central compartment involvement at level VI is common, occurring in 20-90% of cases depending on detection method, representing an early metastatic event. These site-specific patterns align with modern level-based systems, aiding in prognostic assessment. The prognostic implications of nodal involvement are substantial, with ipsilateral single-node (N1) conferring better outcomes than contralateral or multiple nodes (N2/N3), where 5-year overall can drop below 50%. Involvement of levels and signals advanced , increasing the risk of distant spread and reducing rates compared to upper-level metastases. Extracapsular extension further worsens , halving 5-year to approximately 50% in affected cases. Molecular markers also modulate outcomes in nodal metastases. In oropharyngeal HNSCC, human papillomavirus (HPV)-positive tumors exhibit improved survival, with 3-year overall survival rates around 82% even with nodal involvement, compared to 57% in HPV-negative counterparts. This disparity highlights the favorable biology of HPV-driven disease despite frequent level II involvement.

Diagnostic approaches

The evaluation of cervical lymph nodes begins with a thorough , which involves systematic of the neck regions to assess for . Nodes larger than 1 cm in diameter, firm or rubbery in consistency, fixed to underlying structures, or associated with tenderness warrant further investigation, as these features raise suspicion for malignancy, while bilateral involvement may suggest such as or . Ultrasound serves as the first-line imaging modality for superficial cervical lymph nodes due to its non-invasiveness, real-time capability, and high of 80-97% for detecting metastatic involvement. Suspicious sonographic features include a rounded shape with a short-to-long axis ratio greater than 0.5, loss of the fatty hilum, heterogeneous echotexture, and peripheral rather than hilar vascularity on Doppler assessment, which collectively improve specificity when combined with findings. For deeper or less accessible nodes, computed tomography () or magnetic resonance imaging () provides detailed anatomical evaluation, particularly assessing size (short-axis diameter >10 mm), irregular borders, and central , which is highly indicative of . Positron emission tomography-computed tomography (PET-) complements these by detecting metabolic activity, with standardized uptake values (SUV) greater than 3 often signifying , offering a of approximately 80-90% for nodal staging in head and neck cancers. Findings are typically localized using the standard node levels I-VI to guide management. As of 2025, advancements in , including models applied to images, have shown promise in enhancing the qualitative of , achieving high accuracy in distinguishing reactive from metastatic nodes. When reveals suspicious features, is essential for definitive . (FNA), often -guided, yields diagnostic material in 70-95% of cases for cytology, enabling rapid assessment of or , though it may require core needle for inadequate samples or detailed . Indications include nodes with abnormal size, shape, or vascularity on , or persistent enlargement despite conservative measures.

Surgical management

Neck dissection classifications

Neck dissection classifications refer to standardized surgical approaches for removing cervical s in the management of head and neck cancers, categorized by the extent of resection and preservation of non-lymphatic structures to balance oncologic efficacy with functional outcomes. These classifications, developed through consensus guidelines, guide the selection of based on tumor , nodal involvement, and primary , often incorporating the level-based anatomical to define targeted lymph node levels I through VI. Radical neck dissection (RND) is the most extensive procedure, involving en bloc removal of all lymph node levels I-V, along with the , , and , typically indicated for advanced nodal disease such as N2 or N3 stages where these structures are directly involved by tumor. This approach, historically the gold standard, sacrifices major non-lymphatic structures to ensure complete oncologic clearance but is now reserved for cases with significant extracapsular spread or invasion. Modified radical neck dissection (MRND) represents a less invasive of , removing all lymph node levels I-V while preserving at least one non-lymphatic structure—such as the spinal accessory nerve (type I), and spinal accessory nerve (type II), or all three major structures including the (type III)—and serves as the standard for most clinically node-positive (cN+) necks without extensive structural invasion. Type III MRND, in particular, is commonly employed when disease is confined to lymph nodes with limited extracapsular extension, minimizing postoperative morbidity while achieving comparable regional control to . Extended neck dissection (END) involves the removal of additional levels or non-lymphatic structures beyond those in RND, such as level Vb, retropharyngeal nodes, or skin/, indicated for tumors with involvement in these areas. Selective neck dissection (SND) targets specific levels based on the primary tumor's predictable patterns of , sparing non-lymphatic structures and levels at low risk, such as the supraomohyoid SND that removes levels I-III for oral cavity cancers like those of the or floor of . This approach is tailored to the primary site—for instance, levels II-IV for laryngeal tumors—and is preferred for early-stage or elective treatment of clinically node-negative (cN0) necks with high metastatic risk. These procedures are indicated for clinically node-positive (cN+) disease or high-risk cN0 necks (e.g., T3-T4 primaries with >20% occult metastasis probability), with 5-year regional control rates ranging from 80% to 95% when combined with radiotherapy or , depending on nodal and .

Postoperative considerations

Following neck dissection, immediate recovery focuses on managing shoulder dysfunction, which arises from sacrifice or injury to the spinal accessory nerve and results in complaints of pain and dysfunction in 30-70% of patients after radical procedures. Pain management employs multimodal approaches, including opioids, nonsteroidal anti-inflammatory drugs, and regional nerve blocks to alleviate postoperative discomfort and facilitate mobility. Surgical drains are standardly placed to prevent seroma accumulation by continuously suctioning lymphatic fluid and potential hematomas, typically removed once output falls below 20-30 mL per day. Postoperative complications vary by dissection extent but include chyle in 2-5% of cases, often due to injury during level IV dissection, presenting as milky and managed conservatively or with reoperation. Wound occurs in about 5% of patients, while formation affects 2-7%, both necessitating prompt and antibiotics to avoid further morbidity. , characterized by neck swelling from lymphatic disruption, can develop in up to 75% of patients following combined and radiotherapy and may require compression or manual . Long-term considerations involve cosmetic outcomes such as visible scarring and facial asymmetry, which can impact , alongside functional deficits like when level VI nodes are excised, potentially requiring swallowing rehabilitation. Surveillance protocols emphasize imaging, including , MRI, or every 3-6 months in the first two years post-surgery to detect recurrence early, with frequency tapering based on risk. Advances in robotic-assisted neck dissection, introduced post-2010, have demonstrated reduced morbidity compared to open techniques through minimized incision size and improved nerve preservation.

References

  1. [1]
    Anatomy, Head and Neck, Lymph Nodes - StatPearls - NCBI Bookshelf
    Illustrated anatomy includes the cervical lymph nodes, lymphatics of the mammary gland, cisterna chyli, lumbar lymph nodes, pelvic lymph nodes, lymphatics of ...
  2. [2]
    Lymphatic Drainage of the Head and Neck - TeachMeAnatomy
    ### Summary of Lymphatic Drainage of the Head and Neck (Cervical Lymph Nodes)
  3. [3]
    Cervical lymph nodes: anatomy, groups and drainage | Kenhub
    The cervical lymph nodes are la arge group of lymph nodes that drain the neck region and associated structures. Learn about their anatomy now on Kenhub!
  4. [4]
    Anatomy, Lymph Nodes - StatPearls - NCBI Bookshelf - NIH
    Jul 25, 2023 · Lymph nodes are found at the convergence of major blood vessels, and an adult will have approximately 800 nodes commonly sited in the neck, ...
  5. [5]
    Cervical: Lymphadenopathy - PMC - PubMed Central - NIH
    The neck region contains around 300 lymph nodes (LNs) out of 800 LNs in the whole body. The detailed study of LNs by Rouviere in 1932 [1] and the later ...Missing: total | Show results with:total
  6. [6]
    Ultrasonographic Appearances of Cervical Lymph Nodes in Healthy ...
    Normal cervical lymph nodes are oval, with an unsharp border and an echogenic hilum but no relation between the age, gender and BMI.
  7. [7]
    Lymphatic Senescence: Current Updates and Perspectives - PMC
    Apr 3, 2021 · In eldery people, atrophy of the lymphatic muscles and a decrease in the elastic lymphatic matrix is seen, which leads to sclerosis of the ...
  8. [8]
    Aging-Related Cellular, Structural and Functional Changes in the ...
    The aging of lymph nodes results in decreased cell transport to and within the nodes, a disturbance in the structure and organization of nodal zones.Missing: cervical | Show results with:cervical
  9. [9]
    Histology, Lymph Nodes - StatPearls - NCBI Bookshelf - NIH
    Lymph nodes are involved in the production of both cellular and humoral immunity. They filter all kinds of foreign material, viruses, bacteria, and tumor cells.
  10. [10]
    Histopathology of the Lymph Nodes - PMC - PubMed Central - NIH
    The structures within a lymph node include the capsule, subcapsular sinus, cortex (B cell zone with follicles and germinal centers), paracortex (T cell zone), ...
  11. [11]
    The lymphatic system throughout history: From hieroglyphic ...
    Apr 9, 2022 · 1.2.​​ The Hippocratic author described lymph nodes specifically in the axilla, around the ears, near the jugular vessels, the groin, the ...Missing: neck | Show results with:neck
  12. [12]
    Thomas Wharton's Adenographia, first published in London in 1656 ...
    Wharton integrated contemporary anatomical discoveries with a focus on the function of glands and their relationship to the nervous system.Missing: nodes | Show results with:nodes
  13. [13]
    [PDF] Lorenz heister's handbook of surgery in the ... - Repozitorij MEDRI
    the axillary lymph nodes and the pectoralis major muscle in cases of cancer. In the fifth section the author describes an ope- ration on the abdomen for ...Missing: cervical | Show results with:cervical
  14. [14]
    Imaging-Based Nodal Classification for Evaluation of Neck ...
    This study was undertaken to create an imaging-based classification for the lymph nodes of the neck that will be readily accepted by clinicians.
  15. [15]
    Virchow Node - StatPearls - NCBI Bookshelf
    Jun 2, 2025 · Virchow node, a left supraclavicular lymph node, was first described in 1848 by German pathologist Rudolf Ludwig Karl Virchow (1821-1901) as an indicator of ...Definition/Introduction · Issues of Concern · Clinical Significance
  16. [16]
    Historical milestones in the evolution of the procedure of neck ...
    For instance, the classification that was given by Rouvière divides the cervical lymph nodes broadly into various groups with defined anatomical boundaries.
  17. [17]
    Neck Dissection: An Operation in Evolution: Hayes Martin Lecture
    Lest we think that the issue of comprehensive vs partial neck dissection is a new one, Dr George Crile, who is considered to be the first to describe RND, also ...
  18. [18]
    History/Classification of Nodal Levels and Neck Dissections | Ento Key
    Feb 14, 2020 · The lymph nodes of the head and neck region have been designated in various ways over the years. The first fundamental nomenclature of the neck ...
  19. [19]
    Standardizing neck dissection terminology. Official report of the ...
    Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg. 1991 Jun;117(6):601-5. doi: 10.1001/archotol ...
  20. [20]
    Neck Dissection Classification Update: Revisions Proposed by the ...
    Robbins KT Pocket Guide to Neck Dissection, Classification and TNM Staging of Head and Neck Cancer. Alexandria, Va: American Academy of Otolaryngology Head and ...
  21. [21]
    [PDF] IV. DEFINITION OF LYMPH NODE GROUPS (FIGURE 1) Level IA
    The superior boundary is the apex formed by a convergence of the sternocleidomastoid and the trapezius mus- cles, the inferior boundary is the clavicle, the ...
  22. [22]
    Head and neck cancers—major changes in the American Joint ...
    Jan 27, 2017 · The eighth edition Head and Neck AJCC Cancer Staging Manual incorporates significant changes based on advances in our understanding of the ...Background on the AJCC... · Cancer Staging... · Changes to Staging in HR...
  23. [23]
    Comparing the AJCC Cancer Staging Seventh and Eighth Editions
    Second, for nodal (N) category, superior mediastinal lymph node disease (level VII) is now included with central cervical lymph node (level VI) as N1a ...
  24. [24]
    Differentiated and anaplastic thyroid carcinoma: Major changes in ...
    Nov 1, 2017 · This is a review of the major changes in the American Joint Committee on Cancer staging manual, eighth edition, for differentiated and anaplastic thyroid ...
  25. [25]
    Levels of the neck and classification of neck dissection and incisions
    This review discusses the history of neck dissection levels to its current accepted classification by the American Head and Neck Society, the evolving types of ...
  26. [26]
    Cervical Lymph Nodes of the Neck: Drainage & Levels
    Jul 27, 2024 · Level 5 Cervical Lymph Nodes ; Superior: Skull base SCM and trapezius muscles ; Inferior: Clavicle ; Anterior: Posterior border of the SCM muscle ...
  27. [27]
    Skip metastases to lateral cervical lymph nodes in differentiated ...
    Apr 24, 2019 · In more rare cases, metastases to lateral neck compartment without central lymph node metastasis (so called “skip metastases”) could be observed ...
  28. [28]
    Anatomy, Lymphatic System - StatPearls - NCBI Bookshelf - NIH
    Mar 6, 2023 · Lymph nodes serve as a filter and function to monitor lymphatic fluid/blood composition, drain excess tissue fluid and leaked plasma proteins, ...
  29. [29]
    The impact of size on particle drainage dynamics and antibody ...
    Mar 10, 2021 · Such findings confirm previous studies highlighting the ability of nanoparticles ranging from 20 to 200 nm to directly drain to the LNs [36,37].
  30. [30]
    Dendritic cell-based immunotherapy for head and neck squamous ...
    The most notable ability of cDC1s is antigen cross-presentation. They uptake antigens from necrotic tumor cells, transport them to draining lymph nodes, and ...
  31. [31]
    Tumor Antigen Cross-Presentation and the Dendritic Cell - NIH
    Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that are critical for the generation of effective cytotoxic T lymphocyte (CTL) ...
  32. [32]
    The Humoral Immune Response Is Initiated in Lymph Nodes by B ...
    Apr 27, 2007 · We show that antigen-specific B cells residing in the follicles acquire antigen within minutes of injection, first in the region closest to the subcapsular ...
  33. [33]
    High endothelial venules (HEVs) in immunity, inflammation and cancer
    High endothelial venules (HEVs) are specialized blood vessels mediating lymphocyte trafficking to lymph nodes (LNs) and other secondary lymphoid organs.Missing: cervical | Show results with:cervical
  34. [34]
    [PDF] Dendritic cells control lymphocyte entry to lymph nodes through high ...
    Nov 13, 2011 · Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels ...
  35. [35]
    Antigen-specific IgA response of NALT and cervical lymph node ...
    We examined the occurrence of antigen-specific antibody forming cells in mononuclear cells (MNC) of nasopharynx associated lymphoid tissues (NALT) and cervical ...Missing: mucosal drainage
  36. [36]
    IgA and Mucosal Homeostasis - Madame Curie Bioscience Database
    IgA antibodies perform their protective functions discretely without interfering with the physiological activities of mucosal membranes.
  37. [37]
    Altered immune landscape of cervical lymph nodes reveals Epstein ...
    Feb 21, 2025 · The adaptive immune response against EBV occurs in the deep cervical lymph nodes (dcLNs) (11). CNS lymphatics carrying neuronal autoantigens ...
  38. [38]
    Competition for IL-2 between Regulatory and Effector T Cells to ...
    In this review we discuss how the competition for cytokines between different cells of the immune system can shape the system wide immune response.
  39. [39]
    Lymphadenopathy - StatPearls - NCBI Bookshelf
    Lymphadenopathy is a common abnormal finding during the physical exam in general medical practice. It can be caused by neoplasm, inflammatory conditions, or ...
  40. [40]
    An approach to cervical lymphadenopathy in children - PMC - NIH
    Cervical lymphadenopathy is a common problem in children, with reactive lymphadenopathy from a variety of viral infections being the most common cause. In ...
  41. [41]
    Adenopathy - StatPearls - NCBI Bookshelf - NIH
    Posterior cervical lymphadenopathy can arise from localized bacterial and viral infections, as well as lymphoma.Adenopathy · Histopathology · History And Physical<|control11|><|separator|>
  42. [42]
    Relationship between level of lymph node metastasis and survival in ...
    Feb 15, 2017 · More than 50% of head and neck squamous cell carcinoma (HNSCC) patients present with regional lymph node involvement at the time of diagnosis.
  43. [43]
    Patterns of cervical lymph node metastasis from squamous ...
    Lymph node metastases were confirmed histologically in 82% of 776 therapeutic neck dissections, and micrometastases were discovered in 33% of 343 elective RNDs.
  44. [44]
    Head and Neck Cancer: An Overview - PMC - PubMed Central - NIH
    In general, the nodes most at risk for metastasis from oral cavity malignancy are in levels I, II, and III. The specific subsite of the lesion within the oral ...Overview By Subsite · Oropharynx · Larynx
  45. [45]
    Nodal metastases in thyroid cancer: prognostic implications and ...
    Metastases to regional cervical lymph nodes (LNs) occur early and frequently in patients with differentiated thyroid cancer (DTC) [1]. The prognostic ...
  46. [46]
    Head and Neck Squamous Cell Cancer: Approach to Staging ... - NCBI
    Feb 11, 2024 · Tongue-based SCC can occasionally bypass the level II nodes and spread to an ipsilateral level III or IV nodes. This information can ...
  47. [47]
    Squamous cell carcinoma metastatic to cervical lymph nodes ... - NIH
    Metastases of SCC from unknown primary origin to cervical lymph nodes represent 2% to 7% of head and neck cancers[3]. The management of these metastases remains ...
  48. [48]
    Diagnosis and management of neck metastases from an unknown ...
    Metastases in the upper and middle neck (levels I-II-III-V) are generally attributed to head and neck cancers, whereas the lower neck (level IV) involvement is ...
  49. [49]
    Extracapsular spread in the clinically negative neck (N0) - PubMed
    The presence of extracapsular spread further reduces the survival by 50% in those patients with cervical metastatic disease. Most patients with clinically ...
  50. [50]
    Human Papillomavirus and Survival of Patients with Oropharyngeal ...
    The 3-year rates of overall survival were 82.4% (95% CI, 77.2 to 87.6) in the HPV-positive subgroup and 57.1% (95% CI, 48.1 to 66.1) in the HPV-negative ...
  51. [51]
    Peripheral Lymphadenopathy: Approach and Diagnostic Tools - PMC
    TB also involves the cervical lymph node in 60% to 90% of cases;21 they are firm and non-tender and are known as atypical TB.
  52. [52]
    Ultrasound of malignant cervical lymph nodes - PMC - NIH
    Malignant lymph nodes in the neck include metastases and lymphoma. Cervical nodal metastases are common in patients with head and neck cancers, ...Metastases · Lymphoma · Contrast Enhanced Ultrasound...
  53. [53]
    Review of ultrasonography of malignant neck nodes - PubMed Central
    Ultrasonography (97%) has higher sensitivity than palpation (73%) in the assessment of cervical lymph nodes, and has a high specificity (93%) when combined ...
  54. [54]
    Ultrasound criteria of malignancy for cervical lymph nodes ... - PubMed
    Cystic appearance, hyperechoic punctuations, loss of hilum, and peripheral vascularization can be considered as major ultrasound criteria of LN malignancy.
  55. [55]
    Lymph node assessment in cervical cancer: current approaches - PMC
    Nov 11, 2024 · Traditionally, lymphadenectomy was the only way to accurately determine the LN status. Currently, several options exist: LN dissection, imaging ...
  56. [56]
    MRI and PET/CT in the assessment of lymph node metastases ... - NIH
    Nov 7, 2023 · The aim of this study is to present the diagnostic accuracy of MRI and PET/CT in the evaluation of cervical lymph nodes in patients with head and neck cancer ( ...
  57. [57]
    Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal ... - NIH
    Nov 8, 2016 · The presence of cervical lymph node metastasis is an important prognostic factor for patients with head and neck squamous cell carcinomas (HNSCC) ...
  58. [58]
    The Diagnostic Value of Fine-Needle Aspiration Cytology in Cervical ...
    Sep 29, 2023 · The most common FNAC findings were lymphomas and reactive lymph nodes (26.2% and 19.7%, respectively). The positive predictive value of FNAC was ...
  59. [59]
    Accuracy of ultrasound-guided fine-needle aspiration for small ...
    May 14, 2024 · This study aimed to evaluate the accuracy of ultrasound-guided FNA in determining the etiology of small cervical lymph nodes.
  60. [60]
    Diagnostic Accuracy of Lymph Nodes Fine Needle Aspiration Biopsy ...
    This study determined a sensitivity value of 92.9%, indicating that the FNAB examination can diagnose benign lymph node abnormalities. In contrast, the negative ...
  61. [61]
    Neck Cancer Resection and Dissection - StatPearls - NCBI Bookshelf
    Aug 8, 2023 · Modified radical neck dissection type II (MRND-II): Removal of lymph nodes from level I-V and ipsilateral sternocleidomastoid muscle, with ...
  62. [62]
    Radical Neck Dissection - StatPearls - NCBI Bookshelf
    A neck dissection is generally indicated for any clinically positive nodal disease or advanced tumor stage in node-negative disease (T3-T4). Radical neck ...Missing: oncology | Show results with:oncology
  63. [63]
    Standards and Definitions in Neck Dissections of Differentiated ...
    Radical neck dissection (RND) is accepted as the standard basic procedure in defining neck dissections.
  64. [64]
    Neck dissection: MedlinePlus Medical Encyclopedia
    Oct 28, 2024 · Modified radical neck dissection. This is the most common type of neck dissection. All lymph nodes are removed. Less neck tissue is taken out ...Missing: oncology | Show results with:oncology
  65. [65]
    Extent of neck dissection for patients with clinical N1 oral cancer - NIH
    Mar 5, 2020 · Supraomohyoid neck dissection (SOHND) is classified as a selective dissection of levels I, II, and III of the neck [1]. Since skip ...
  66. [66]
    Retrospective Study of Selective Submandibular Neck Dissection ...
    In clinically N1 necks, the regional control rates were 81.3% with SMND and 83.0% with RND (P = 0.72), and the DSS rates were 81.3% and 80.0%, respectively, (P ...
  67. [67]
    Patterns of regional recurrence in papillary thyroid cancer patients ...
    May 31, 2017 · With the selective dissection group, the 5-year regional control rate was equally high at 91%, with only 5 cases of regional recurrence in ...
  68. [68]
    Acupuncture for Pain and Dysfunction After Neck Dissection - NIH
    As such, complaints of neck or shoulder pain and dysfunction are common in 30% to 70% of patients after classical radical neck dissection, depending on how ...Missing: permanent | Show results with:permanent
  69. [69]
    MANAGEMENT OF CHYLE LEAK FOLLOWING HEAD AND NECK ...
    The rate of iatrogenic lymphatic injuries is 2-8% after neck dissection and 0.5-1.4% after thyroidectomy (1). Thoracic duct injuries are more common and present ...
  70. [70]
    Incidence and Clinical Analysis of Complications of Neck Dissection
    Mar 8, 2021 · Post-operative complications noted were wound dehiscence in 22.6%, infection in 20.7%, hematoma in 2.7%, salivary fistula in 11.7% and nerve ...
  71. [71]
    Selective Neck Dissection in Oral Cavity Cancer Is Not Without ... - NIH
    Shoulder dysfunction is reported in 7 to 20% at 6 months, lymphedema from 19 to 26%, marginal mandibular nerve problems in 10 to 30%, and scar-related problems ...
  72. [72]
    Postoperative Neck Ultrasonography Surveillance After ... - NIH
    Mar 15, 2018 · This study aimed to assess an appropriate interval and frequency of postoperative neck US surveillance for detecting tumor recurrence in patients who had ...
  73. [73]
    A scoping review of endoscopic and robotic techniques for lateral ...
    Feb 8, 2024 · Endoscopic and robotic techniques for LND are safe, with improved cosmetic results and comparable oncologic and surgical outcomes.